Hematologic Malignancy: Clinical Trials

8 trials for Hematologic Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 withdrawn. 8 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Withdrawn 8
Phase 12Withdrawn 2

Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TCR Alpha/Beta and CD19-deplete Haplo-HSCT
CliniMACS Plus Instrument - Pediatric Patients, Hematologic Malignancy
Phase 2WithdrawnUniversity of Colorado, Denver2024-12-012024-10-18
CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
CliniMACS, Bone Marrow Transplant, Hyperfractionated Total Body Irradiation - Hematologic Diseases, Hematologic Malignancy
Phase 2WithdrawnBaptist Health South Florida2022-09-012022-09-27
Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies
Hematopoietic Stem Cells from HLA-compatible Related, Hematopoietic Stem Cells from HLA Unrelated - B-Cell Lymphoid Malignancies, Hematologic Malignancy
Phase 2WithdrawnBaptist Health South Florida2022-03-282023-11-01
MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
MPH966, Placebo - Hematologic Malignancy
Phase 1 / Phase 2WithdrawnNelson Chao2021-09-012020-03-20
Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)
Hydroxychloroquine Sulfate 200 MG [Plaquenil], Azithromycin 250 MG Oral Capsule, Placebo oral tablet - COVID19, Hematologic Malignancy
Phase 2WithdrawnInstitut de cancérologie Strasbourg Europe2020-09-022020-09-04
Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies
Fludarabine, Cytarabine, Erwinase - Hematologic Malignancy
Phase 2WithdrawnM.D. Anderson Cancer Center2018-05-012018-06-26
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
Treg cells, CD3+ Teff cells, Fludarabine - Hematologic Malignancy, Acute Myeloid Leukemia
Phase 1 / Phase 2WithdrawnMasonic Cancer Center, University of Minnesota2014-01-012017-12-02
Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation
TXA127 - Cord Blood Transplant, Hematologic Malignancy
Phase 2WithdrawnTarix Pharmaceuticals2012-03-012016-08-31

Narrower conditions

Hematologic Neoplasms (8)  ·  Leukemia, Myeloid, Acute (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Burkitt Lymphoma (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  COVID-19 (1)  ·  Hematologic Diseases (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Prolymphocytic (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)

Broader conditions

Hemic and Lymphatic Diseases (8)  ·  Neoplasms (8)  ·  Neoplasms by Site (8)  ·  Hematologic Diseases (7)  ·  Immune System Diseases (4)  ·  Immunoproliferative Disorders (4)  ·  Lymphatic Diseases (4)  ·  Lymphoproliferative Disorders (4)  ·  Neoplasms by Histologic Type (4)  ·  Disease Attributes (3)  ·  Infections (3)  ·  Leukemia (3)  ·  Leukemia, Lymphoid (3)  ·  Leukemia, Myeloid (3)  ·  Pathologic Processes (3)

Interventions

fludarabine (3)  ·  Cyclophosphamide (2)  ·  fludarabine phosphate (2)  ·  Asparaginase (1)  ·  Azithromycin (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Cord Blood Stem Cell Transplantation (1)  ·  Cytarabine (1)  ·  Hydroxychloroquine (1)  ·  Melphalan (1)  ·  Thiotepa (1)  ·  Whole-Body Irradiation (1)  ·  angiotensin I (1-7) (1)  ·  asparaginase erwinia chrysanthemi recombinant (1)

Sponsors

Baptist Health South Florida (2)  ·  Institut de cancérologie Strasbourg Europe (1)  ·  M.D. Anderson Cancer Center (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Nelson Chao (1)  ·  Tarix Pharmaceuticals (1)  ·  University of Colorado, Denver (1)

Countries

United States (5)  ·  France (1)

Top investigators

Alisa B Lee Sherick (1)  ·  Anthony Sung, MD (1)  ·  Claudio Brunstein, MD, PhD (1)  ·  Guenther Koehne, MD (1)  ·  Guenther Koehne, MD, PhD (1)  ·  Joanne Kurtzberg, MD (1)  ·  Kristin Page, MD (1)  ·  Tapan Kadia, MD (1)